Measures · D06 in 2015 · Part D · DD3 Member Experience with the Drug Plan
Rating of Drug Plan
Drug PlanMember ExperienceSource: CAHPS
- What it measures
- Percent of the best possible score the plan earned from members who rated the prescription drug plan.
- How it's calculated
- This case-mix adjusted measure is used to assess the overall view members have of their prescription drug plan. The Consumer Assessment of Healthcare Providers and Systems (CAHPS) score uses the mean of the distribution of responses converted to a scale from 0 to 100. The score shown is the percentage of the best possible score each contract earned.
- Data source
- CAHPS CAHPS Survey Questions (question numbers vary depending on survey type): • Using any number from 0 to 10, where 0 is the worst prescription drug plan possible and 10 is the best prescription drug plan possible, what number would you use to rate your prescription drug plan?
- Measurement period
- 02/15/2014 - 05/31/2014
- Better when
- Higher
- Weight
- 1.5 (Patients’ Experience and Complaints Measure)
- Star assignment
- Relative Distribution and Significance Testing
- Case-mix adjusted
- —
- In improvement measure
- Yes
- Used in CAI
- —
- Notes
- CAHPS Survey results were sent to each contract's Medicare Compliance Officer in early August 2014. These reports provide further explanation of the CAHPS scoring methodology and provide detailed information on why a specific rating was assigned.
From the 2015 Star Ratings Technical Notes (CMS).
Cut points over time
Score needed to earn each star level. Part D thresholds differ for MA-PD and standalone PDP contracts. Dotted lines and open dots: where the cut points may move for 2028.
How the 2028 cut points are projected
Each boundary moves by its median year-on-year change since 2019. It's the same projection the Star outlook uses for every contract. CMS sets real cut points from all contracts' scores each year, so treat these as a direction, not a forecast of the exact number.
| Stars | Org type | 2027 | Projected 2028 | Move |
|---|---|---|---|---|
| 2★ | MA-PD | 84 | 85 | +1 |
| 3★ | MA-PD | 86 | 86 | 0 |
| 4★ | MA-PD | 87 | 87 | 0 |
| 5★ | MA-PD | 89 | 89 | 0 |
| 2★ | PDP | 82 | 82 | 0 |
| 3★ | PDP | 83 | 83 | 0 |
| 4★ | PDP | 86 | 86 | 0 |
| 5★ | PDP | 88 | 88 | 0 |
2015 star distribution
Not rated: Plan too new to be measured (157); Plan too small to be measured (67); Plan not required to report measure (13)
Cut point bands
| Star year | Org type | 1★ | 2★ | 3★ | 4★ | 5★ |
|---|---|---|---|---|---|---|
| 2027 | MA-PD | < 84 | >= 84 to < 86 | >= 86 to < 87 | >= 87 to < 89 | >= 89 |
| 2027 | PDP | < 82 | >= 82 to < 83 | >= 83 to < 86 | >= 86 to < 88 | >= 88 |
| 2026 | MA-PD | < 85 | >= 85 to < 86 | >= 86 to < 88 | >= 88 to < 89 | >= 89 |
| 2026 | PDP | < 82 | >= 82 to < 83 | >= 83 to < 86 | >= 86 to < 88 | >= 88 |
| 2025 | MA-PD | < 84 | >= 84 to < 86 | >= 86 to < 87 | >= 87 to < 89 | >= 89 |
| 2025 | PDP | < 79 | >= 79 to < 82 | >= 82 to < 85 | >= 85 to < 87 | >= 87 |
| 2024 | MA-PD | < 84 | >= 84 to < 85 | >= 85 to < 87 | >= 87 to < 89 | >= 89 |
| 2024 | PDP | < 80 | >= 80 to < 81 | >= 81 to < 83 | >= 83 to < 87 | >= 87 |
| 2023 | MA-PD | < 83 | >= 83 to < 85 | >= 85 to < 87 | >= 87 to < 88 | >= 88 |
| 2023 | PDP | < 79 | >= 79 to < 80 | >= 80 to < 83 | >= 83 to < 87 | >= 87 |
| 2022 | MA-PD | < 84 | >= 84 to < 85 | >= 85 to < 87 | >= 87 to < 88 | >= 88 |
| 2022 | PDP | < 80 | >= 80 to < 82 | >= 82 to < 84 | >= 84 to < 87 | >= 87 |
| 2021 | MA-PD | < 83 | >= 83 to < 84 | >= 84 to < 86 | >= 86 to < 87 | >= 87 |
| 2021 | PDP | < 80 | >= 80 to < 81 | >= 81 to < 83 | >= 83 to < 87 | >= 87 |
| 2020 | MA-PD | < 83 | ? 83 to < 84 | ? 84 to < 86 | ? 86 to < 87 | ? 87 |
| 2020 | PDP | < 80 | ? 80 to < 81 | ? 81 to < 83 | ? 83 to < 87 | ? 87 |
| 2019 | MA-PD | < 82 | ? 82 to < 83 | ? 83 to < 85 | ? 85 to < 87 | ? 87 |
| 2019 | PDP | < 80 | ? 80 to < 81 | ? 81 to < 84 | ? 84 to < 86 | ? 86 |
| 2018 | MA-PD | < 81 | ? 81 to < 83 | ? 83 to < 85 | ? 85 to < 86 | ? 86 |
| 2018 | PDP | < 80 | ? 80 to < 81 | ? 81 to < 83 | ? 83 to < 87 | ? 87 |
| 2017 | MA-PD | < 80 | ? 80 to < 82 | ? 82 to < 84 | ? 84 to < 86 | ? 86 |
| 2017 | PDP | < 79 | ? 79 to < 80 | ? 80 to < 83 | ? 83 to < 86 | ? 86 |
| 2016 | MA-PD | < 80 | ? 80 to < 82 | ? 82 to < 84 | ? 84 to < 86 | ? 86 |
| 2016 | PDP | < 80 | ? 80 to < 81 | ? 81 to < 82 | ? 82 to < 86 | ? 86 |
| 2015 | MA-PD | < 82% | ? 82% to < 83% | ? 83% to < 84% | ? 84% to < 87% | ? 87% |
| 2015 | PDP | < 80% | ? 80% to < 81% | * | ? 81% to < 86% | ? 86% |
Lowest-scoring contracts, 2015
| Contract | Parent | Members | Score | Stars | Δ | Shortfall to 4★ | Pctile |
|---|---|---|---|---|---|---|---|
| S5960 Wellpoint | Elevance Health, Inc. | 14,108 | 77 | 1 | — | 4 | 0% |
| H2836 Anthem Blue Cross and Blue Shield | Elevance Health, Inc. | 2,426 | 75 | 1 | — | 9 | 0% |
| H8552 Anthem Blue Cross Life and Health Insurance Company | Elevance Health, Inc. | 1,065 | 76 | 1 | — | 8 | 0% |
| H6923 AETNA HEALTH, INC. (PA) | Aetna Inc. | — | 77 | 1 | — | 7 | 0% |
| H7908 AETNA HEALTH, INC. (PA) | Aetna Inc. | — | 78 | 1 | — | 6 | 1% |
| H3107 OXFORD HEALTH PLANS (NJ), INC. | UnitedHealth Group, Inc. | — | 78 | 1 | — | 6 | 1% |
| H3370 EMPIRE HEALTHCHOICE HMO, INC. | Anthem Inc. | — | 78 | 1 | — | 6 | 1% |
| H4910 AETNA HEALTH, INC. (PA) | Aetna Inc. | — | 78 | 1 | — | 6 | 1% |
| H5009 Regence BlueShield | Cambia Health Solutions, Inc. | 10,384 | 79 | 1 | — | 5 | 2% |
| H3337 LIBERTY HEALTH ADVANTAGE, INC. | Liberty Health Advantage, Inc. | — | 79 | 1 | — | 5 | 2% |
| R3332 Florida Blue | Guidewell Mutual Holding Corporation | — | 79 | 1 | — | 5 | 2% |
| H4011 MMM HEALTHCARE, LLC. | InnovaCare Inc. | — | 79 | 1 | — | 5 | 2% |
| R5941 Anthem Blue Cross and Blue Shield | Elevance Health, Inc. | 13,077 | 79 | 1 | — | 5 | 2% |
| H3347 Elderplan | Elderplan, Inc. | 27,294 | 79 | 1 | — | 5 | 2% |
| H3379 UnitedHealthcare | UnitedHealth Group, Inc. | 102,401 | 79 | 1 | — | 5 | 2% |
| S6506 Blue Cross Blue Shield of Arizona (AZ Blue) | Blue Cross Blue Shield of Arizona | — | 79 | 1 | — | 2 | 2% |
| S3440 ALLIANCE HEALTH AND LIFE INSURANCE COMPANY | Henry Ford Health System | — | 79 | 1 | — | 2 | 2% |
| S5768 WellCare | Centene Corporation | — | 79 | 1 | — | 2 | 2% |
| R5287 UNITEDHEALTHCARE INSURANCE COMPANY | UnitedHealth Group, Inc. | — | 80 | 1 | — | 4 | 4% |
| H5823 Molina Healthcare of Washington, Inc. | Molina Healthcare, Inc. | 13,098 | 80 | 1 | — | 4 | 4% |
| H2905 SIERRA HEALTH AND LIFE INSURANCE COMPANY, INC. | UnitedHealth Group, Inc. | — | 80 | 1 | — | 4 | 4% |
| H5529 COMMUNITY INSURANCE COMPANY | WellPoint, Inc. | — | 80 | 1 | — | 4 | 4% |
| H3342 Anthem Blue Cross and Blue Shield | Elevance Health, Inc. | — | 80 | 1 | — | 4 | 4% |
| H3528 ConnectiCare | Molina Healthcare, Inc. | 47,034 | 80 | 1 | — | 4 | 4% |
| H5106 Highmark Blue Cross Blue Shield | Highmark Health | 16,043 | 80 | 1 | — | 4 | 4% |
History
| Star year | Code | Name | Measured | Weight | Source |
|---|---|---|---|---|---|
| 2027 | D05 | Rating of Drug Plan | 03/2026 – 06/2026 | 2 | CAHPS |
| 2026 | D05 | Rating of Drug Plan | 03/2025 – 05/2025 | 2 | CAHPS |
| 2025 | D05 | Rating of Drug Plan | 03/2024 – 06/2024 | 4 | CAHPS |
| 2024 | D05 | Rating of Drug Plan | 03/2023 – 06/2023 | 4 | CAHPS |
| 2023 | D05 | Rating of Drug Plan | 03/2022 – 06/2022 | 4 | CAHPS |
| 2022 | D05 | Rating of Drug Plan | 03/2021 – 05/2021 | 2 | CAHPS |
| 2021 | D07 | Rating of Drug Plan | 03/2019 – 05/2019 | 2 | CAHPS |
| 2020 | D07 | Rating of Drug Plan | 03/2019 – 05/2019 | 1.5 | CAHPS |
| 2019 | D07 | Rating of Drug Plan | 03/2018 – 06/2018 | 1.5 | CAHPS |
| 2018 | D08 | Rating of Drug Plan | 03/2017 – 06/2017 | 1.5 | CAHPS |
| 2017 | D08 | Rating of Drug Plan | 02/2016 – 08/2016 | 1.5 | CAHPS |
| 2016 | D08 | Rating of Drug Plan | 02/15/2015 - 05/31/2015 | 1.5 | CAHPS |
| 2015 | D06 | Rating of Drug Plan | 02/15/2014 - 05/31/2014 | 1.5 | CAHPS |